Plasma acetate, gluconate and interleukin-6 profiles during and after cardiopulmonary bypass: A comparison of Plasma-Lyte 148 with a bicarbonate-balanced solution

Critical Care

Volumn 15, Issue 1, 2011, Pages

  Davies, Paul G ^a   Venkatesh, Balasubramanian ^a   Morgan, Thomas J ^a   Presneill, Jeffrey J ^a   Kruger, Peter S ^a   Thomas, Bronwyn J ^a   Roberts, Michael S ^a   Mundy, Julie ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; ACETIC ACID PLUS GLUCONATE SODIUM PLUS MAGNESIUM CHLORIDE PLUS POTASSIUM CHLORIDE PLUS SODIUM CHLORIDE; BICARBONATE; GLUCONIC ACID; INTERLEUKIN 6; MAGNESIUM ION; POTASSIUM; SODIUM; ACETIC ACID DERIVATIVE; ISOTONIC SOLUTION; MAGNESIUM CHLORIDE; PLASMA LYTE 148; POTASSIUM CHLORIDE; SODIUM CHLORIDE;

AGED; ARTERIAL BLOOD; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; ELECTROLYTE BLOOD LEVEL; FEMALE; HUMAN; MAGNESIUM BLOOD LEVEL; MALE; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; SODIUM BLOOD LEVEL; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; INTRAOPERATIVE PERIOD; METHODOLOGY; MIDDLE AGED; POSTOPERATIVE PERIOD; TIME; TREATMENT OUTCOME;

ACETATES; AGED; BICARBONATES; CARDIOPULMONARY BYPASS; FEMALE; GLUCONATES; HUMANS; INTERLEUKIN-6; INTRAOPERATIVE PERIOD; ISOTONIC SOLUTIONS; MAGNESIUM CHLORIDE; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; TIME FACTORS; TREATMENT OUTCOME;

EID: 78651353615     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc9966     Document Type: Article

References (30)

1. Ailawadi G, Zacour RK. Cardiopulmonary bypass/extracorporeal membrane oxygenation/left heart bypass: indications, techniques, and complications. Surg Clin North Am 2009, 89:781-796. vii-viii, 10.1016/j.suc.2009.05.006, 19782837.
2. Harris EA, Seelye ER, Barratt-Boyes BG. Respiratory and metabolic acid-base changes during cardiopulmonary bypass in man. Br J Anaesth 1970, 42:912-922. 10.1093/bja/42.11.912, 5488356.
3. Liskaser FJ, Bellomo R, Hayhoe M, Story D, Poustie S, Smith B, Letis A, Bennett M. Role of pump prime in the etiology and pathogenesis of cardiopulmonary bypass-associated acidosis. Anesthesiology 2000, 93:1170-1173. 10.1097/00000542-200011000-00006, 11046201.
4. Hayhoe M, Bellomo R, Liu G, McNicol L, Buxton B. The aetiology and pathogenesis of cardiopulmonary bypass-associated metabolic acidosis using polygeline pump prime. Intensive Care Med 1999, 25:680-685. 10.1007/s001340050930, 10470571.
5. Himpe D, Neels H, De Hert S, Van Cauwelaert P. Adding lactate to the prime solution during hypothermic cardiopulmonary bypass: a quantitative acid-base analysis. Br J Anaesth 2003, 90:440-445. 10.1093/bja/aeg084, 12644414.
6. Liskaser F, Story DA, Hayhoe M, Poustie SJ, Bailey MJ, Bellomo R. Effect of pump prime on acidosis, strong-ion-difference and unmeasured ions during cardiopulmonary bypass. Anaesth Intensive Care 2009, 37:767-772.
7. Takkunen O, Salmenpera M, Heinonen J. Comparison of Ringer's acetate and lactate solutions as a prime for cardiopulmonary bypass. Ann Chir Gynaecol 1985, 74:223-227.
8. Morgan TJ, Power G, Venkatesh B, Jones MA. Acid-base effects of a bicarbonate-balanced priming fluid during cardiopulmonary bypass: comparison with Plasma-Lyte 148. A randomised single-blinded study. Anaesth Intensive Care 2008, 36:822-829.
9. Lilley A. The selection of priming fluids for cardiopulmonary bypass in the UK and Ireland. Perfusion 2002, 17:315-319. 10.1191/0267659102pf538oa, 12243433.
10. Sobieski MA, Slaughter MS, Hart DE, Pappas PS, Tatooles AJ. Prospective study on cardiopulmonary bypass prime reduction and its effect on intraoperative blood product and hemoconcentrator use. Perfusion 2005, 20:31-37. 10.1191/0267659105pf783oa, 15751668.
11. Bingel M, Lonnemann G, Koch KM, Dinarello CA, Shaldon S. Enhancement of in-vitro human interleukin-1 production by sodium acetate. Lancet 1987, 1:14-16. 10.1016/S0140-6736(87)90703-3, 2879093.
12. Thaha M, Yogiantoro M, Soewanto, Pranawa. Correlation between intradialytic hypotension in patients undergoing routine hemodialysis and use of acetate compared in bicarbonate dialysate. Acta Med Indones 2005, 37:145-148.
13. Veech RL, Gitomer WL. The medical and metabolic consequences of administration of sodium acetate. Adv Enzyme Regul 1988, 27:313-343. 10.1016/0065-2571(88)90024-6, 2854950.
14. Schrander-vd Meer AM, ter Wee PM, Kan G, Donker AJ, van Dorp WT. Improved cardiovascular variables during acetate free biofiltration. Clin Nephrol 1999, 51:304-309.
15. Quebbeman EJ, Maierhofer WJ, Piering WF. Mechanisms producing hypoxemia during hemodialysis. Crit Care Med 1984, 12:359-363. 10.1097/00003246-198404000-00004, 6705543.
16. Jacob AD, Elkins N, Reiss OK, Chan L, Shapiro JI. Effects of acetate on energy metabolism and function in the isolated perfused rat heart. Kidney Int 1997, 52:755-760. 10.1038/ki.1997.392, 9291197.
17. Selby NM, Fluck RJ, Taal MW, McIntyre CW. Effects of acetate-free double-chamber hemodiafiltration and standard dialysis on systemic hemodynamics and troponin T levels. ASAIO J 2006, 52:62-69. 10.1097/01.mat.0000189725.93808.58, 16436892.
18. Kveim M, Bredesen JE. A gas chromatographic method for determination of acetate levels in body fluids. Clin Chim Acta 1979, 92:27-32. 10.1016/0009-8981(79)90392-9, 421344.
19. Smith RF, Humphreys S, Hockaday TD. The measurement of plasma acetate by a manual or automated technique in diabetic and non-diabetic subjects. Ann Clin Biochem 1986, 23:285-291.
20. Naylor JM, Forsyth GW. The alkalinizing effects of metabolizable bases in the healthy calf. Can J Vet Res 1986, 50:509-516. 1255256, 3024796.
21. Richards RH, Vreman HJ, Zager P, Feldman C, Blaschke T, Weiner MW. Acetate metabolism in normal human subjects. Am J Kidney Dis 1982, 2:47-57.
22. Kveim M, Nesbakken R. Utilization of exogenous acetate during canine haemorrhagic shock. Scand J Clin Lab Invest 1979, 39:653-658. 10.3109/00365517909108870, 43582.
23. Steinberg JB, Kapelanski DP, Olson JD, Weiler JM. Cytokine and complement levels in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993, 106:1008-1016.
24. Tamayo E, Alvarez FJ, Alonso O, Castrodeza J, Bustamante R, Gomez-Herreras JI, Florez S, Rodriguez R. The inflammatory response to colloids and crystalloids used for pump priming during cardiopulmonary bypass. Acta Anaesthesiol Scand 2008, 52:1204-1212. 10.1111/j.1399-6576.2008.01758.x, 18823458.
25. Traverso LW, Hollenbach SJ, Bolin RB, Langford MJ, DeGuzman LR. Fluid resuscitation after an otherwise fatal hemorrhage: II. Colloid solutions. J Trauma 1986, 26:176-182. 10.1097/00005373-198602000-00015, 3080603.
26. Westaby S. Organ dysfunction after cardiopulmonary bypass. A systemic inflammatory reaction initiated by the extracorporeal circuit. Intensive Care Med 1987, 13:89-95. 10.1007/BF00254791, 3553271.
27. Jakob SM, Ensinger H, Takala J. Metabolic changes after cardiac surgery. Curr Opin Clin Nutr Metab Care 2001, 4:149-155. 10.1097/00075197-200103000-00012, 11224661.
28. Murthi SB, Wise RM, Weglicki WB, Komarov AM, Kramer JH. Mg-gluconate provides superior protection against postischemic dysfunction and oxidative injury compared to Mg-sulfate. Mol Cell Biochem 2003, 245:141-148. 10.1023/A:1022840704157, 12708753.
29. Haase M, Haase-Fielitz A, Bellomo R, Devarajan P, Story D, Matalanis G, Reade MC, Bagshaw SM, Seevanayagam N, Seevanayagam S, Doolan L, Buxton B, Dragun D. Sodium bicarbonate to prevent increases in serum creatinine after cardiac surgery: a pilot double-blind, randomized controlled trial. Crit Care Med 2009, 37:39-47. 10.1097/CCM.0b013e318193216f, 19112278.
30. Hicks CI, Gallardo JP, Guillory JK. Stability of sodium bicarbonate injection stored in polypropylene syringes. Am J Hosp Pharm 1972, 29:210-216.